New ETF Book by Larry Connors - Click here to read more
Market Maker Friction Factor is shown in the chart below:
Symbol Change % BuyVol Buy% SellVol Sell% NetVol Friction
CBG $1.07 28.38% 4,926,359 42.42% 4,182,347 36.01% 744,012 6,953
OPTR $1.13 18.90% 319,710 51.68% 298,723 48.29% 20,987 186
SGMO $0.28 14.36% 116,633 54.91% 95,787 45.09% 20,846 745
ZZ $0.28 13.79% 130,546 61.69% 69,555 32.87% 60,991 2,178
PLD $0.60 13.42% 4,208,468 47.26% 3,409,363 38.29% 799,105 13,318
GMCR $3.32 12.97% 526,139 59.62% 345,227 39.12% 180,912 545
Click here to view chart: http://www.buyins.com/fftopgainer11-13-08.jpg
Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have very low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent. Since late October market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock.
For example, the chart above shows GMCR with a Friction Factor of 545 shares. That means that it only takes 545 more shares of buying than selling to move GMCR higher by one penny. This means the Market Makers are allowing the stock to move up quickly as of this morning (low friction).
CB Richard Ellis Group, Inc. (NYSE: CBG), through its subsidiaries, operates as a commercial real estate services company worldwide. It provides advisory services, which include real estate services, such as strategic advice and execution to owners, investors, and occupiers of real estate in connection with leasing, disposition, and acquisition of property; capital market services, principally origination and servicing of commercial mortgage loans; and valuation services, including market value appraisals, litigation support, discounted cash flow analyses, and feasibility and fairness opinions. The company also offers outsourcing services comprising corporate services, including transaction management, project management, facilities management, strategic consulting, portfolio management, and other services to corporations, health care institutions, and public sector entities with real estate portfolios; and asset services, such as Property Management, construction management, marketing, leasing, accounting, and financial services for office, industrial, and retail properties owned by local, regional, and institutional investors. In addition, CB Richard Ellis Group provides investment management services to pension plans, investment funds, and other organizations investing in real estate. Further, it offers development services that comprise site identification, due diligence, and acquisition; procurement of approvals and permits; project finance advisory services; coordination of project design and engineering; construction bidding and management, and tenant finish coordination; and project close-out and tenant move coordination. The company was founded in 1906 and is based in Los Angeles, California.
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR), a biopharmaceutical company, focuses on discovering, developing, and commercializing anti-infective products. The company develops products that treat gastrointestinal infections and related diseases. Its two late-stage anti-infective product candidates include OPT-80, an antibiotic in two Phase III registration trials for the treatment of Clostridium difficile-infections/Clostridium difficile-associated disease, the common nosocomial diarrhea; and Prulifloxacin, an antibiotic in two Phase III trials for the treatment of infectious diarrhea in travelers, a community-acquired infection, which is caused by a range of bacteria. It also develops OPT-1068/CEM-101, a pre-clinical antibiotic against respiratory tract infections; an OPopS drug discovery platform; OPT-822, a carbohydrate-based immunostimulant therapy for the treatment of metastatic breast cancer that completed phase I trials; and OPT-88 as a disease-modifying intra-articular and as a therapy for osteoarthritis. The company has a collaborative research and development, and license agreement with Cempra Pharmaceuticals, Inc. to discover, develop, and commercialize drugs based on macrolide and ketolide compounds. Optimer Pharmaceuticals was founded 1998 and is headquartered in San Diego, California.
Sangamo BioSciences, Inc. (NASDAQ: SGMO | Quote | Chart | News | PowerRating) focuses on the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. Its ZFPs could be engineered to make ZFP transcription factors (ZFP TFs), proteins that can be used to turn genes on or off; and ZFP nucleases, proteins that enable to modify DNA sequences in various ways. The company's ZFP Therapeutic, SB-509, a plasmid formulation of a ZFP TF activator of the vascular endothelial growth factor-A (VEGF-A) gene, is in Phase 2 clinical trials for the treatment of diabetic neuropathy (DN). It also involves in preclinical development programs of ZFP therapeutics that focus on spinal cord injury, stroke, traumatic brain injury, neuropathic pain, and Parkinson?s disease. In addition, the company has research-stage programs in X-linked severe combined immunodeficiency (X-linked SCID), hemophilia, and hemoglobinopathies. It has strategic partnerships with companies, including Dow AgroSciences, LLC and Sigma-Aldrich Corporation, as well as research and license agreements with various life sciences companies, such as Pfizer, Inc.; Novo Nordisk, Inc.; Novartis A/G; Amgen, Inc.; Kirin Brewery Company; Medarex, Inc.; and Genentech, Inc. The company was founded in 1995 and is based in Richmond, California.
Sealy Corporation (NYSE: ZZ | Quote | Chart | News | PowerRating) engages in the manufacture and marketing of a line of bedding products in the United States and internationally. It offers mattresses and mattress foundations. The company?s innerspring bedding products are sold under Sealy, Sealy Posturepedic, Stearns & Foster, and Bassett brand names. Sealy Corporation also manufactures and markets visco-elastic and latex bedding products under the TrueForm, SpringFree, Stearns & Foster, Reflexions, Carrington Chase, MirrorForm, and Pirelli brands. It serves various outlets, including furniture stores, specialty bedding stores, department stores, and warehouse club stores. The company was founded in 1984 and is based in Trinity, North Carolina.
ProLogis (NYSE: PLD | Quote | Chart | News | PowerRating) operates as a real estate investment trust in the United States. It owns, operates, and develops industrial distribution properties in North America, Europe, and Asia. The company operates in three segments: Property Operations, Fund Management, and Corporate Distribution Facilities Services (CDFS). The Property Operations segment engages in the ownership, management, and leasing of industrial distribution and retail properties. As of December 31, 2005, this segment consisted of 1,461 operating properties with approximately 186.7 million square feet. The Fund Management segment provides investment management services for unconsolidated property funds and other properties. As of the above date, this segment had investments in approximately 14 property funds. The CDFS segment primarily develops properties that are contributed to a property fund or sold to third parties. This segment also engages in commercial mixed-use development activities, such as selling the land or completed projects to third parties. As of the above date, this segment had approximately 72 distribution properties. As a REIT, the company would not be subject to federal tax to the extent that it distributes at least 90% of its taxable income to its shareholders. It has a strategic cooperation agreement with China National Materials Storage & Transportation Co. and Zhongchu Development Stock Co., Ltd. to develop logistics and storage markets. The company also has a joint venture agreement with K Raheja Corp. for the acquisition and development of properties in Mumbai, Chennai, Delhi, Bengaluru, Kolkata, and Pune, India. ProLogis was founded as Security Capital Industrial Trust in 1991 and changed its name to ProLogis Trust in 1998. Subsequently, it changed its name to ProLogis. The company is headquartered in Denver, Colorado.
Green Mountain Coffee Roasters, Inc. (NASDAQ: GMCR), through its subsidiaries, engages in roasting, packaging, and distributing roasted coffee primarily in the northeastern United States. It sells approximately 100 whole bean and ground coffee selections, hot cocoa, teas, and coffees. The company offers Arabica coffees and coffee selections, including single-origins, estates, certified organics, Fair Trade Certified, proprietary blends, and flavored coffees under the ?Green Mountain Coffee Roasters? and Newman's Own Organics brands. Green Mountain Coffee Roasters sells coffee to retailers, including supermarkets; convenience stores; specialty stores; food service enterprises, including restaurants, hotels, universities, and business offices; and directly to individual consumers. In addition, it manufactures gourmet single-cup brewing systems and markets its patented single-cup coffee and tea brewing systems for the office and the home under the Keurig brand name. The company was founded in 1981 as Green Mountain Coffee Inc. and changed its name in 2003. Green Mountain Coffee is headquartered in Waterbury, Vermont.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,200,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. None of the companies in this report have paid to be included in this report. From time to time we will mention a company that may have previously paid $995 per month for market data purchased from BUYINS.NET. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
BUYINS.NET, FRICTION FACTOR and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
